Cathie's Ark Logo
undefined Logo

ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily

TherapeuticsGene TherapyCAR-T Cell TherapyCRSPR Gene Editing
Morning Brew Icon
China's One Ocean Problem
Date
Direction
Shares
Fund Weight
Fund
February 13, 2024
BUY228.975k0.2057%ARKK
January 24, 2024
BUY22.571k0.0182%ARKK
January 23, 2024
BUY9.174k0.0074%ARKK
January 17, 2024
BUY133.183k0.1026%ARKK
January 16, 2024
BUY35.486k0.0274%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
4.93%$4.67b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
6🇨🇭Switzerland
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
6$62.32
🎫ARK Ownership Percent
6.67%

Other ETFs That Hold CRSP

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.7%
GNOMGlobal X Genomics & Biotechnology ETF3.52%
ARKKARK Innovation ETF3.37%
XBISPDR® S&P Biotech ETF1.01%
IBBiShares Biotechnology ETF0.35%
LABUS&P Biotech Bull 3X Shares ETF0.242%

Research Notes and Commentary for CRSP

No Research Notes Found for CRSP